The Food and Drug Administration (FDA) Center for Biologics Evaluation and Research (CBER) Biologics Effectiveness and Safety (BEST) Initiative: How Informatics Can Assist the Secondary Use of Electronic Health Records to Inform Regulatory Decisions.
Azadeh ShoaibiHui-Lee WongChristian ReichKeran MollTina Hernandez-BoussardPublished in: AMIA (2020)